17-7235668-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024297.3(PHF23):āc.1170G>Cā(p.Glu390Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000826 in 1,614,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024297.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF23 | NM_024297.3 | c.1170G>C | p.Glu390Asp | missense_variant | 5/5 | ENST00000320316.8 | NP_077273.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF23 | ENST00000320316.8 | c.1170G>C | p.Glu390Asp | missense_variant | 5/5 | 1 | NM_024297.3 | ENSP00000322579.3 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000437 AC: 109AN: 249424Hom.: 0 AF XY: 0.000392 AC XY: 53AN XY: 135332
GnomAD4 exome AF: 0.000867 AC: 1268AN: 1461800Hom.: 1 Cov.: 30 AF XY: 0.000835 AC XY: 607AN XY: 727202
GnomAD4 genome AF: 0.000427 AC: 65AN: 152368Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.1170G>C (p.E390D) alteration is located in exon 5 (coding exon 5) of the PHF23 gene. This alteration results from a G to C substitution at nucleotide position 1170, causing the glutamic acid (E) at amino acid position 390 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at